Complete CTXR Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
CTXR Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 3 peer companies in Healthcare
P/E Ratio
$-15.30
-1977.7%
Peer Median: 62.4x
EV/EBITDA
$0.00
-100.0%
Peer Median: 45.6x
P/S Ratio
$0.23
-72.3%
Peer Median: 14.9x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for CTXR's business model and current situation.
Multiple Comparison
| Multiple | CTXR Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -3.3x | 62.4x | 62.4x | -105.3% | Undervalued |
| EV/EBITDA | Infinityx | 45.6x | 45.6x | Infinity% | Overvalued |
| P/S Ratio | 53.8x | 14.9x | 14.9x | 261.4% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.01B | 0.0x | 0.0x | 38.3x | |
| $0.01B | 0.0x | 0.0x | 53.8x | |
| $729.23B | 62.4x | 45.6x | 14.9x |